By now, most plandemic skeptics are aware of the fact that ivermectin, a cheap, off-patent anti-malaria drug, is a powerful remedy for the Wuhan coronavirus (Covid-19), hence why the government does not want people to have it. But did you also know that ivermectin treats cancer?
At least nine different peer-reviewed studies demonstrate how safe and effective ivermectin wards off the Big C, threatening the multi-billion dollar cancer industry. There are two industries, in other words, that ivermectin threatens: the covid industry and the cancer industry.
1) In 2017, research published in the journal Biochemical and Biophysical Research Communications found that ivermectin preferentially treats renal cell carcinoma (RCC) while protecting normal kidney cells. RCC tumor growth is also delayed by ivermectin, which induces mitochondrial dysfunction and oxidative stress while increasing mitochondrial biogenesis.
2) A year later, research published in the journal Molecular Medicine Reports found…
View original post 420 more words